Eric Ciamporcero

1.9k total citations
28 papers, 1.4k citations indexed

About

Eric Ciamporcero is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric Ciamporcero has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric Ciamporcero's work include Renal cell carcinoma treatment (5 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Eric Ciamporcero is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Eric Ciamporcero collaborates with scholars based in Italy, United States and United Kingdom. Eric Ciamporcero's co-authors include Giuseppina Barrera, Stefania Pizzimenti, Chiara Dianzani, Martina Daga, Роберто Пили, Piergiorgio Pettazzoni, Rosalba Minelli, Kiersten Marie Miles, Alessio Lepore and Fabrizio Gentile and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Eric Ciamporcero

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Ciamporcero Italy 18 739 219 201 179 171 28 1.4k
Si Chen China 26 952 1.3× 101 0.5× 219 1.1× 167 0.9× 215 1.3× 83 2.0k
Myeong‐Sok Lee South Korea 26 1.2k 1.6× 154 0.7× 239 1.2× 120 0.7× 272 1.6× 83 2.1k
Claudia Bocca Italy 25 747 1.0× 97 0.4× 197 1.0× 115 0.6× 345 2.0× 59 1.8k
Cheng‐Hao Jin China 29 1.1k 1.5× 104 0.5× 234 1.2× 79 0.4× 200 1.2× 112 2.3k
Stefania Bulotta Italy 27 1.0k 1.4× 112 0.5× 245 1.2× 135 0.8× 264 1.5× 60 2.4k
Isabelle Roland Belgium 21 667 0.9× 144 0.7× 190 0.9× 116 0.6× 129 0.8× 29 1.4k
Feifei Yang China 23 748 1.0× 89 0.4× 234 1.2× 79 0.4× 188 1.1× 83 1.5k
Mysore S. Veena United States 19 944 1.3× 122 0.6× 308 1.5× 57 0.3× 327 1.9× 28 1.9k
Antonina Azzolina Italy 28 916 1.2× 89 0.4× 201 1.0× 93 0.5× 229 1.3× 53 2.0k

Countries citing papers authored by Eric Ciamporcero

Since Specialization
Citations

This map shows the geographic impact of Eric Ciamporcero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ciamporcero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ciamporcero more than expected).

Fields of papers citing papers by Eric Ciamporcero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ciamporcero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ciamporcero. The network helps show where Eric Ciamporcero may publish in the future.

Co-authorship network of co-authors of Eric Ciamporcero

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Ciamporcero. A scholar is included among the top collaborators of Eric Ciamporcero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Ciamporcero. Eric Ciamporcero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steenbrugge, Jonas, Kristel Demeyere, Olivier De Wever, et al.. (2021). OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. npj Breast Cancer. 7(1). 27–27. 6 indexed citations
2.
Elbanna, May, Ashley Orillion, Nur P. Damayanti, et al.. (2019). Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma. Molecular Cancer Therapeutics. 19(1). 147–156. 10 indexed citations
3.
Ciamporcero, Eric, Martina Daga, Stefania Pizzimenti, et al.. (2017). Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer. Free Radical Biology and Medicine. 115. 447–457. 67 indexed citations
4.
Ramakrishnan, Swathi, Sheng‐Yu Ku, Eric Ciamporcero, et al.. (2016). HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma. BMC Cancer. 16(1). 617–617. 35 indexed citations
5.
Daga, Martina, Chiara Ullio, Monica Argenziano, et al.. (2016). GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses. Free Radical Biology and Medicine. 97. 24–37. 67 indexed citations
6.
Arcaro, Alessia, Martina Daga, Giovanni Paolo Cetrangolo, et al.. (2015). Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines. Oxidative Medicine and Cellular Longevity. 2015. 1–13. 8 indexed citations
7.
Ciamporcero, Eric, He Shen, Swathi Ramakrishnan, et al.. (2015). YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage. Oncogene. 35(12). 1541–1553. 108 indexed citations
8.
Pizzimenti, Stefania, Martina Daga, Eric Ciamporcero, et al.. (2015). Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models. Journal of Biomedical Nanotechnology. 11(12). 2169–2185. 7 indexed citations
9.
Adelaiye‐Ogala, Remi, Eric Ciamporcero, Kiersten Marie Miles, et al.. (2014). Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications. Molecular Cancer Therapeutics. 14(2). 513–522. 56 indexed citations
10.
Shen, Li, Anette Sundstedt, Michael J. Ciesielski, et al.. (2014). Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models. Cancer Immunology Research. 3(2). 136–148. 74 indexed citations
11.
Barrera, Giuseppina, Stefania Pizzimenti, Eric Ciamporcero, et al.. (2014). Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases. Antioxidants and Redox Signaling. 22(18). 1681–1702. 109 indexed citations
12.
Ciamporcero, Eric, Kiersten Marie Miles, Remi Adelaiye‐Ogala, et al.. (2014). Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models. Molecular Cancer Therapeutics. 14(1). 101–110. 77 indexed citations
13.
Ramakrishnan, Swathi, Sheng‐Yu Ku, Wendy M. Swetzig, et al.. (2014). Abstract 4061: Evidence for hdac6 and er-α association in a subset of clear cell renal cell carcinoma. Cancer Research. 74(19_Supplement). 4061–4061. 1 indexed citations
14.
Miles, Kiersten Marie, Mukund Seshadri, Eric Ciamporcero, et al.. (2014). Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts. PLoS ONE. 9(11). e112371–e112371. 47 indexed citations
15.
Pizzimenti, Stefania, Eric Ciamporcero, Martina Daga, et al.. (2013). Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Frontiers in Physiology. 4. 242–242. 288 indexed citations
16.
Toaldo, Cristina, Stefania Pizzimenti, Piergiorgio Pettazzoni, et al.. (2012). AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells. PPAR Research. 2012. 1–16. 24 indexed citations
17.
Toaldo, Cristina, Rosalba Minelli, Eric Ciamporcero, et al.. (2012). Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells. PLoS ONE. 7(6). e40149–e40149. 30 indexed citations
18.
Minelli, Rosalba, Roberta Cavalli, Leigh Ellis, et al.. (2012). Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells. European Journal of Pharmaceutical Sciences. 47(4). 686–694. 68 indexed citations
19.
Pettazzoni, Piergiorgio, Eric Ciamporcero, Claudio Medana, et al.. (2011). Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. Free Radical Biology and Medicine. 51(8). 1610–1618. 24 indexed citations
20.
Pucci, Angela, Elvis Brscic, Stefania Pizzimenti, et al.. (2011). PPARγ in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment. Atherosclerosis. 218(2). 479–485. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Si Chen Breakdown of academic impact, for papers by Myeong‐Sok Lee Breakdown of academic impact, for papers by Claudia Bocca Breakdown of academic impact, for papers by Cheng‐Hao Jin Breakdown of academic impact, for papers by Stefania Bulotta Breakdown of academic impact, for papers by Isabelle Roland Breakdown of academic impact, for papers by Feifei Yang Breakdown of academic impact, for papers by Mysore S. Veena Breakdown of academic impact, for papers by Antonina Azzolina
Rankless by CCL
2026